Results of BioSante’s 2A/Furin technology in industrial antibody CHO expression system announced
Results of BioSante’s 2A/Furin technology in industrial antibody CHO expression system announced
BioSante Pharmaceuticals, Inc. today announced that results of an evaluation of its 2A/Furin technology by Novartis Pharma AG in its industrial antibody CHO expression system were published in the Journal of Applied Microbiology & Biotechnology. The results demonstrate that the 2A/Furin technology was integrated successfully into a plasmid-based, industrial-scale, CHO antibody cell line …
Read more on News-Medical-Net
More Meth Drug Addiction Info:
- Taylor Koa Series K20ce Dreadnought Acoustic-Electric Guitar …
- Top 3 Premarket Stocks to Watch « Sumfolio.com :: Financial News …
- CAR FEATURE>> RE-AMEMIYA FURIN KAZAN – Speedhunters
- BioSante Pharmaceuticals Announces Novartis' Successful Use of 2A …
- BioSante Pharmaceuticals, Inc. To Present at the Rodman & Renshaw …
- Furin Targeted Drug Delivery for Treatment of Rhabdomyosarcoma in …
- Top Day Trader Alerts (BPAX, CNTF, GERN, HAUP, NTES, GOLD, SIRI …
- BioSante Pharmaceuticals Gains 6% on Published Study Results for …